RMG Wealth Management’s K O S PHARMACEUTICALS INC KOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-563
Closed -$63K 670
2025
Q4
$63K Buy
563
+110
+24% +$12.3K 0.01% 139
2025
Q3
$58.3K Buy
453
+43
+10% +$5.53K 0.01% 128
2025
Q2
$51K Buy
+410
New +$51K 0.01% 132

RMG Wealth Management's KOSP Position: Q1 2026 in Review

RMG Wealth Management sold out of K O S PHARMACEUTICALS INC (KOSP) in Q1 2026, closing a stake of 563 shares — an estimated $63K sold.

RMG Wealth Management first reported a position in KOSP in Q2 2025 and held it in 3 quarters. The position peaked at $63K in Q4 2025. 0 funds tracked by Wall St. Rank hold KOSP as of Q1 2026.

  • RMG Wealth Management reported no remaining K O S PHARMACEUTICALS INC position as of Q1 2026 after selling out during the quarter.
  • RMG Wealth Management sold 563 K O S PHARMACEUTICALS INC shares in Q1 2026, an estimated $63K.
  • RMG Wealth Management first reported a position in K O S PHARMACEUTICALS INC in Q2 2025 and held it in 3 quarters.
  • RMG Wealth Management's K O S PHARMACEUTICALS INC position peaked at $63K in Q4 2025.
  • 0 funds tracked by Wall St. Rank held K O S PHARMACEUTICALS INC as of Q1 2026.

Based on RMG Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.